Welcome to our dedicated page for Pyrophyte Acquisition II SEC filings (Ticker: PAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Pyrophyte Acquisition II's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Pyrophyte Acquisition II's regulatory disclosures and financial reporting.
Pyrophyte Acquisition Corp. II (PAII) filed its Q3 report, highlighting its post‑IPO SPAC status and capital position. The company completed its IPO and a partial over‑allotment, placing $200,411,500 into a U.S. trust account and reporting trust assets of $202,044,257 as of September 30, 2025. Net income for the quarter was $1,437,769, driven primarily by interest on trust investments, while general and administrative expenses were $195,104.
PAII sold 20,041,150 units at $10.00 per unit, each with one Class A share and one‑half warrant; private placement warrants totaled 5,050,000 at a $1.00 price. Deferred underwriting fees are $9,399,690. Cash outside the trust was $721,227 at quarter‑end to fund ongoing SPAC operating needs.
Public shareholders may redeem Class A shares in connection with an initial business combination or if no deal is completed within 24 months from the IPO closing. As of November 14, 2025, 20,041,150 Class A and 7,225,721 Class B ordinary shares were outstanding.
Pyrophyte Acquisition Corp. II (PAII) received an Amendment No. 1 to Schedule 13G from Harraden Circle entities, reporting beneficial ownership of 0 shares and 0% of the Class A Common Stock. The event date is 09/30/2025.
The filing lists multiple Harraden-affiliated funds and control entities, all showing no sole or shared voting or dispositive power. The signatory certified the securities were not acquired or held to change or influence control, consistent with a passive Schedule 13G filing.
Pyrophyte Acquisition Corp. II Schedule 13G discloses that Linden-related entities and Siu Min (Joe) Wong beneficially own between 1,101,657 and 1,150,000 Class A ordinary shares as of September 16, 2025. Those holdings represent approximately 5.5% (Linden GP and Linden Capital) and 5.7% (Linden Advisors and Mr. Wong) of the 20,041,150 shares outstanding cited from the issuer's September 2, 2025 quarterly report. The filing states shared voting and dispositive power only, and includes a certification that the shares were not acquired to change or influence control of the issuer.
FAQ
What is the current stock price of Pyrophyte Acquisition II (PAII)?
What is the market cap of Pyrophyte Acquisition II (PAII)?
